✦ LIBER ✦

New horizons in hepatitis C therapy

Book ID: 120868090
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2000
Weight: 179 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200012650-00025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Once-daily simeprevir in combination wit

Once-daily simeprevir in combination with pegylated-interferon and ribavirin: a new horizon in the era of direct-acting antiviral agent therapy for chronic hepatitis C

✍ Maekawa, Shinya; Enomoto, Nobuyuki 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 128 KB

New therapies on the horizon for hepatit

New therapies on the horizon for hepatitis C

✍ De Francesco, Raffaele; Rice, Charles M. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 464 KB

Hepatitis C: A New Horizon

✍ Kyong-Mi Chang 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Chronic hepatitis B: new therapies on th

Chronic hepatitis B: new therapies on the horizon?

✍ Stephen Pianko; John McHutchison 📂 Article 📅 1999 🏛 The Lancet 🌐 English ⚖ 36 KB

Hepatitis C Virus — Biology, Host Evasio

Hepatitis C Virus — Biology, Host Evasion Strategies, and Promising New Therapies on the Horizon

✍ Sohail A. Qureshi 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 11 KB

Hepatitis C virus—biology, host evasion

Hepatitis C virus—biology, host evasion strategies, and promising new therapies on the horizon

✍ Sohail A. Qureshi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB

## Abstract Hepatitis C reduces the quality of life for some 170 million people around the globe and is one of the most prevalent diseases on the planet. It is caused by the hepatitis C virus (HCV) that is replicated by an error‐prone polymerase and therefore undergoes rapid evolution. To date, alt